生検ガイダンスシステムの世界市場の規模は、2023年に10億5,000万ドルと推定され、2024年から2030年にかけて6.1%のCAGRで成長すると予想されます。この市場の成長に寄与する主な要因は、高齢人口の増加、世界中でのがんの新規発生率の上昇、低侵襲手術への傾斜の高まり、およびイメージング技術の進歩です。3D画像検査や低侵襲治療に生検ガイダンスシステムを使用することへの関心の高まりが、予測期間中の市場の成長を促進すると予想されます。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biopsy Guidance Systems Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Biopsy Guidance Systems Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Biopsy Guidance Systems Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopsy Guidance Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Stereotactic Guided Biopsy
4.3.1. Stereotactic Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Ultrasound Guided Biopsy
4.4.1. Ultrasound Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. MRI Guided Biopsy
4.5.1. MRI Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Biopsy Guidance Systems Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopsy Guidance Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Brain Biopsy
5.3.1. Brain Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Breast Biopsy
5.4.1. Breast Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Biopsy Guidance Systems Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biopsy Guidance Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Biopsy Guidance Systems In Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Specialty Clinics
6.4.1. Biopsy Guidance Systems In Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Biopsy Guidance Systems In Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Research and Academic Institutes
6.6.1. Biopsy Guidance Systems for Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Biopsy Guidance Systems Market: Regional Estimates & Trend Analysis
7.1. Biopsy Guidance Systems Market Share, By Region, 2023 & 2030 (USD Billion)
7.2. North America
7.2.1. North America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Becton, Dickinson, and Company
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Hologic, Inc.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Devicor Medical Products, Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. B. Braun Melsungen AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. ARGON MEDICAL
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Boston Scientific Corporation
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. INRAD Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Cook Medical
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. PLANMED OY
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives